Search Results - "Leclerc, Yves E"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1
  2. 2

    Solitary fibrous tumor arising in the mesentery: a case report by Bouhabel, Sarah, Leblanc, Guy, Ferreira, Jose, Leclerc, Yves E, Dubé, Pierre, Sidéris, Lucas

    Published in World journal of surgical oncology (31-10-2011)
    “…Solitary fibrous tumor (SFT) is a rare mesenchymal neoplasm usually found in the pleura, soft tissues and visceral organs. We describe one case arising in the…”
    Get full text
    Journal Article
  3. 3

    Surgical cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis arising from the appendix by Sideris, Lucas, MD, Mitchell, Andrew, MD, Drolet, Pierre, MD, Leblanc, Guy, MD, Leclerc, Yves E., MD, Dubé, Pierre, MD, MSc

    Published in Canadian Journal of Surgery (01-04-2009)
    “…Background Peritoneal carcinomatosis (PC) originating in the appendix is a rare disease for which the long-term prognosis is poor. The aim of our study was to…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Surgery Should Complement Endocrine Therapy for Elderly Postmenopausal Women with Hormone Receptor-Positive Early-Stage Breast Cancer by Dubé, Pierre, Leclerc, Yves E., Leblanc, Guy, Mitchell, Andrew, Gagnon, Marie-Claude, Drolet, Pierre, Nguyen, Olivier, Sideris, Lucas

    Published in International Journal of Surgical Oncology (01-01-2012)
    “…Introduction. Endocrine therapy (ET) is an integral part of breast cancer (BC) treatment with surgical resection remaining the cornerstone of curative…”
    Get full text
    Journal Article
  6. 6

    Cutaneous Apocrine Carcinoma With an In Situ Component and Histiocytoid and Signet-Ring Cells by Berdugo, Jérémie, Dumont-Mackay, Vincent, Brissy-Lachery, Sophie, Leclerc, Yves E, Doyon, Josée, Mitchell, Andrew, Petrella, Tony, Désy, Delphine

    Published in The American journal of dermatopathology (01-06-2017)
    “…We present a case of cutaneous apocrine carcinoma arising in the axilla of a 71-year-old man. The tumor had a significant component of histiocytoid and…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin for Peritoneal Carcinomatosis Arising from Appendix: Preliminary Results of a Survival Analysis by Marcotte, Eric, Sideris, Lucas, Drolet, Pierre, Mitchell, Andrew, Frenette, Suzanne, Leblanc, Guy, Leclerc, Yves E., Dubé, Pierre

    Published in Annals of surgical oncology (01-10-2008)
    “…Background Peritoneal carcinomatosis (PC) arising from the appendix is a rare disease for which the long-term prognosis is poor. The aim of this study was to…”
    Get full text
    Journal Article
  10. 10

    Phase I study on sentinel lymph node mapping in colon cancer: A preliminary report by Bendavid, Yves, Latulippe, Jean François, Younan, Rami J., Leclerc, Yves E., Dube, Serge, Heyen, Françoise, Morin, Michel, Girard, Robert, Bastien, Edouard, Ferreira, José, Cerino, Michel, Dubé, Pierre

    Published in Journal of surgical oncology (01-02-2002)
    “…Background and Objectives Lymph node (LN) metastasis is one of the most significant prognostic factor in colorectal cancer. In fact, therapeutic decisions are…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Prolonged Therapy with Imatinib Mesylate before Surgery for Advanced Gastrointestinal Stromal Tumor Results of a Phase II Trial by Doyon, C., Sideris, Lucas, Leblanc, Guy, Leclerc, Yves E., Boudreau, D., Dubé, Pierre

    Published in International Journal of Surgical Oncology (01-01-2012)
    “…Purpose. Proven efficacy of imatinib mesylate in gastrointestinal stromal tumour (GIST) has led to its use in advanced disease and, more recently, in adjuvant…”
    Get full text
    Journal Article
  13. 13
  14. 14

    ONLINE ONLY: Complications after colorectal anastomosis in a patient with metastatic rectal cancer treated with systemic chemotherapy and bevacizumab by Akkouche, Amine, Sidéris, Lucas, Leblanc, Guy, Leclerc, Yves-E, Vafiadis, Petro, Dubé, Pierre

    Published in Canadian Journal of Surgery (01-06-2008)
    “…Because the half-life of bevacizumab is 20 (11-50) days, which the drug monograph makes clear, bevacizumab should be stopped 28 days before a surgical…”
    Get full text
    Journal Article
  15. 15

    Pharmacokinetics studies and toxicity profile of raltitrexed used by intraperitoneal route in normothermia in a pig model by Nguyen, Diem, Emond, Claude, Leclerc, Yves, Sherman, Igor, Dube, Pierre

    Published in Medical science monitor (01-01-2003)
    “…To define the pharmacokinetic and toxicity profile of raltitrexed administered by intraperitoneal route in a normothermic pig model. Twenty-one female pigs…”
    Get more information
    Journal Article
  16. 16
  17. 17